MANF and diabetes mellitus: Pre-diabetic NOD mice, at 10 weeks of age, were treated with either AAV8.ins-Manf, AAV8.glu-Manf, AAV8.ins-GFP, or AAV8.glu-GFP vector, and monitored for diabetes development (Figure 1A).